Interventions to treat cutaneous leishmaniasis in children: A systematic review (Q60955896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

0 references

title

Interventions to treat cutaneous leishmaniasis in children: A systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

main subject

infectious disease

0 references

cutaneous leishmaniasis

2 references

12 March 2019

23 March 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

María Del Mar Castro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

author name string

Andrés Uribe-Restrepo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Mayur M Desai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Diana Dávalos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

language of work or name

English

0 references

publication date

14 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

PLoS Neglected Tropical Diseases

14 April 2020

published in

3 references

12 March 2019

23 March 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

e0006986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

14 April 2020

copyright license

2 references

12 March 2019

on focus list of Wikimedia project

23 March 2019

ScienceSource

0 references

cites work

Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis?

1 reference

12 December 2020

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

1 reference

12 December 2020

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

12 December 2020

Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate

1 reference

12 December 2020

Immune response to leishmania: paradox rather than paradigm

1 reference

12 December 2020

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

1 reference

12 December 2020

Interventions for Old World cutaneous leishmaniasis

1 reference

12 December 2020

Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

1 reference

12 December 2020

Interventions for American cutaneous and mucocutaneous leishmaniasis

1 reference

12 December 2020

WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study

1 reference

12 December 2020

Thiopental pharmacokinetics in newborn infants: a case report of overdose.

1 reference

12 December 2020

Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections

1 reference

12 December 2020

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

1 reference

12 December 2020

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

1 reference

12 December 2020

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults

1 reference

12 December 2020

Innovative clinical trial design for pediatric therapeutics

1 reference

12 December 2020

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children

1 reference

12 December 2020

Optimal dosing of miltefosine in children and adults with visceral leishmaniasis

1 reference

12 December 2020

StaR child health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials

1 reference

12 December 2020

Standard 6: age groups for pediatric trials

1 reference

12 December 2020

Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses

1 reference

12 December 2020

Leishmaniasis worldwide and global estimates of its incidence

1 reference

12 December 2020

Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions

1 reference

12 December 2020

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

1 reference

12 December 2020

Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis

1 reference

12 December 2020

Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update

1 reference

12 December 2020

Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment.

1 reference

12 December 2020

Children and cutaneous leishmaniasis: a clinical report and review

1 reference

12 December 2020

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

1 reference

12 December 2020

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults

1 reference

12 December 2020

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.

1 reference

12 December 2020

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.

1 reference

12 December 2020

10.1371/JOURNAL.PNTD.0006986

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30550538%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference